Skip to main content
. 2019 May 21;72(8):542–549. doi: 10.1136/jclinpath-2019-205818

Figure 3.

Figure 3

Kaplan–Meier analysis of the disease-free survival and overall survival of patients with advanced oropharyngeal squamous cell carcinoma. (A,B) Programmed death ligand 1 (PD-L1)+ or PD-L1 tumour cells, (C,D) PD-L1+ or PD-L1 immune cells in the stroma, and (E,F) high or low CD8+ tumour-infiltrated lymphocyte density. Significant differences were evaluated using a log-rank test.